Brief: Amgen And Horizon Therapeutics Plc Resolve FTC Lawsuit, Clearing Path To Close Acquisition
Sept 1 (Reuters) - Amgen Inc AMGN.O :
* AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT,
CLEARING
PATH TO CLOSE ACQUISITION
* NARROW ASSURANCE, FORMALIZED IN THE CONSENT ORDER WITH THE
FTC,
WILL HAVE NO IMPACT ON AMGEN’S BUSINESS
* AMGEN AND HORIZON WILL QUICKLY SEEK THE FINAL APPROVALS
REQUIRED
UNDER IRISH LAW TO CLOSE THE ACQUISITION
* ANTICIPATE BEING ABLE TO CLOSE THE ACQUISITION IN EARLY
FOURTH-QUARTER 2023
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014